ALPS Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

ALPS Advisors’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-112,451	Closed	-$448K	–	1091
2025 Q4	$448K	Buy	112,451 +961	+0.9%	+$4.25K	﹤0.01%	817
2025 Q3	$421K	Buy	+111,490	New	+$378K	﹤0.01%	893
2023 Q4	–	Sell	-60,400	Closed	-$79.7K	–	986
2023 Q3	$79.7K	Sell	60,400 -933	-2%	-$2.05K	﹤0.01%	974
2023 Q2	$183K	Buy	61,333 +6,659	+12%	+$21.4K	﹤0.01%	977
2023 Q1	$189K	Sell	54,674 -1,764	-3%	-$8.54K	﹤0.01%	986
2022 Q4	$236K	Buy	56,438 +11,301	+25%	+$42.8K	﹤0.01%	980
2022 Q3	$181K	Sell	45,137 -3,888	-8%	-$29.5K	﹤0.01%	1008
2022 Q2	$554K	Buy	+49,025	New	+$588K	0.01%	561

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ALPS Advisors's NBP Position: Q1 2026 in Review

ALPS Advisors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 112,451 shares — an estimated $448K sold.

ALPS Advisors first reported a position in NBP in Q2 2022 and held it in 8 quarters. The position peaked at $554K in Q2 2022. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

ALPS Advisors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
ALPS Advisors sold 112,451 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $448K.
ALPS Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2022 and held it in 8 quarters.
ALPS Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $554K in Q2 2022.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.